Pharsight

Drugs that contain Sumatriptan

1. Imitrex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5307953 GLAXOSMITHKLINE Single dose dispenser having a piercing member
Dec, 2012

(11 years ago)

US5307953

(Pediatric)

GLAXOSMITHKLINE Single dose dispenser having a piercing member
Jun, 2013

(10 years ago)

US5554639 GLAXOSMITHKLINE Medicaments
Sep, 2013

(10 years ago)

US5554639

(Pediatric)

GLAXOSMITHKLINE Medicaments
Mar, 2014

(10 years ago)

Market Authorisation Date: 26 August, 1997

Treatment: Method of treating migraine

Dosage: SPRAY;NASAL

More Information on Dosage

IMITREX family patents

Family Patents

2. Tosymra patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8268791 TONIX MEDS Alkylglycoside compositions for drug administration
May, 2026

(1 year, 11 months from now)

US8440631 TONIX MEDS Compositions for drug administration
May, 2026

(1 year, 11 months from now)

US9283280 TONIX MEDS Compositions for drug administration
May, 2026

(1 year, 11 months from now)

US9610280 TONIX MEDS Formulations comprising triptan compounds
Jun, 2030

(6 years from now)

US10603305 TONIX MEDS Formulations comprising triptan compounds
Jun, 2030

(6 years from now)

US9974770 TONIX MEDS Formulations comprising triptan compounds
Jun, 2030

(6 years from now)

US11337962 TONIX MEDS Formulations comprising triptan compounds
Jun, 2030

(6 years from now)

US9211282 TONIX MEDS Formulations comprising triptan compounds
Jul, 2031

(7 years from now)

Market Authorisation Date: 25 January, 2019

Treatment: Acute treatment of migraine

Dosage: SPRAY;NASAL

More Information on Dosage

TOSYMRA family patents

Family Patents